CARM1 and breast cancer: This indicates that CARM1 is essential for oestrogen/ERα‐induced transcriptional activation, breast cancer cell growth, and tumorigenesis, making CARM1 a potential drug target for ERα‐positive and endocrine‐resistant breast cancer [82].